Navigation Links
DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
Date:5/4/2013

Los Angeles, CA (PRWEB) May 04, 2013

The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients who have taken the medication Byetta. A recent study suggests the drug may have higher occurrence rates of pancreatic cancer and thyroid cancer than traditional treatments.

DrugRisk was created to improve the safety of those taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is a twice-daily injectable medication released in 2005 to help those with type-2 diabetes control blood sugar. It generated sales of over $300 million last year, when it was purchased with Amylin Pharmaceuticals by Bristol-Myers Squibb*.

However, DrugRisk has added a 2011 study from UCLA indicating Byetta could increase the risk of pancreatic cancer by 290% and thyroid cancer by 473%**. The Journal for the American Medical Association also recently published findings showing these drugs can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

Now, DrugRisk has added a new report by the Institute for Safe Medication Practices, which found in an analysis of FDA reports that patients were over 20 times as likely to report pancreatitis, pancreatic cancer or thyroid cancer from Januvia than from traditional diabetes treatment like metformin****.

Due to the number of patients filing a Byetta lawsuit alleging cancer, lawyers have asked that cases be consolidated to a special federal multi-district court in California****. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Byetta is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Byetta lawsuits.

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****Institute for Safe Medication Practices, 4/18/13; ismp.org/QuarterWatch/pdfs/2012Q3.pdf
*****JPML, 4/5/13; cdn.aboutlawsuits.com/wp-content/uploads/2013-04-05-Incretin-Mimetics-MDL.pdf

Read the full story at http://www.prweb.com/releases/byetta-lawsuit/side-effects/prweb10699747.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
2. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
3. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
4. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
5. DrugRisk Announces Launch of Byetta Cancer Resource Center
6. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
7. DrugRisk Announces Addition of Januvia Cancer Resource Center
8. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
9. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
10. DrugRisk Announces Launch of DePuy Hip Resource Center
11. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health ... announced today that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By ... continuum for their patients being treated for substance use. , Enlightened Solutions was ...
(Date:5/5/2016)... ... May 05, 2016 , ... Liposuction specialist Marcia V. ... in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. This year’s conference ... to address the conference about her unique specialization in treating Lipedema. Dr. Byrd is ...
(Date:5/5/2016)... ... ... Nepenthe Laboratory Services (NLS), a premier drug monitoring and toxicology laboratory, held ... donations for Food for Lane County, and to help support awareness for the upcoming ... assembly was to create an exciting atmosphere for the kids at Riverbend to aspire ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Augusta Public ... its school nurses. This partnership will enable school health offices to streamline and bolster ... Butler County, Kansas, just east of Wichita. Augusta public schools serve 2,300 students among ...
(Date:5/5/2016)... ... May 05, 2016 , ... In ... health, today GrassrootsHealth, a public health promotion and research organization, declared May as ... technology-driven society, and other shifts in cultural behavior over the past several decades, ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and ... Thalassaemia Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights - 2016, provides comprehensive ... Thalassaemia market valuations and forecast, Thalassaemia products ...
(Date:5/4/2016)... time for an upgrade. There are many medical recorders on the market but none ... DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller ... innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
Breaking Medicine Technology: